Literature DB >> 3926359

Light chain types of IgD in human bone marrow and serum.

J A van Nieuwkoop, J Radl.   

Abstract

One of the unexplained features of human IgD is its preferential expression with either kappa or lambda light chains in different situations. While the membrane IgD on B lymphocytes shows a predominance of the kappa type, about 90% of all known IgD myeloma proteins and 87% of normal IgD producing plasma cells in spleens of healthy individuals were shown to belong to the lambda type. Very little is known of the kappa/lambda light chain distribution of normal polyclonal IgD in the serum and in the bone marrow plasma cells. In this study, the kappa/lambda representation of IgD in bone marrow plasma cells and in the serum of 25 adult persons (two healthy and 23 suffering from various nonmalignant diseases) was investigated. The kappa/lambda ratio of IgD+ bone marrow plasma cells showed a large variation among the individuals of this group, in 84% of the cases being below 1.0. While about 1/3 of the investigated subjects had 80% or more of IgD of the lambda type (kappa/lambda ratio below 0.2), most showed a kappa/lambda ratio of IgD higher than that, with four persons exhibiting a clear cut predominance of IgD of the kappa type. A positive correlation (Spearman's correlation co-efficient, P = 0.005) between the percentages of IgD+ plasma cells and their kappa/lambda ratio was found. Semiquantitative evaluation of the kappa/lambda composition within the serum IgD by immunoselection was in agreement with the kappa/lambda ratio of IgD+ plasma cells in all individual cases.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3926359      PMCID: PMC1577224     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  The fragmentation of human IgD during storage.

Authors:  F Skvaril; J Rádl
Journal:  Clin Chim Acta       Date:  1967-03       Impact factor: 3.786

2.  Monoclonal IgD. A comparative study of 60 sera with IgD "M" component.

Authors:  J M Fine; C Rivat; P Lambin; C Ropartz
Journal:  Biomedicine       Date:  1974-03-20

3.  Independent movement of IgD and IgM molecules on the surface of individual lymphocytes.

Authors:  W Knapp; R L Bolhuis; J Rádl; W Hijmans
Journal:  J Immunol       Date:  1973-10       Impact factor: 5.422

4.  An immunofluorescence procedure for the detection of intracellular immunoglobulins.

Authors:  W Hijmans; H R Schuit; F Klein
Journal:  Clin Exp Immunol       Date:  1969-04       Impact factor: 4.330

5.  Light chain types in plasma cells that produce IgD.

Authors:  B Pernis; M Governa; D S Rowe
Journal:  Immunology       Date:  1969-05       Impact factor: 7.397

6.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

7.  A research standard for human serum immunoglobulin D.

Authors:  D S Rowe; S G Anderson; L Tackett
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

8.  Selective hyperimmunoglobulinemia A and D in a case with chronic generalized eczema and prolonged sepsis.

Authors:  J Rádl; J Masopust; E Lacková
Journal:  Helv Paediatr Acta       Date:  1967-07

9.  Light chain typing of immunoglobulins in small samples of biological material.

Authors:  J Rádl
Journal:  Immunology       Date:  1970-07       Impact factor: 7.397

10.  Immunoglobulin D as a lymphocyte receptor.

Authors:  D S Rowe; K Hug; L Forni; B Pernis
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

View more
  2 in total

1.  Immunological studies in the hyper-immunoglobulin D syndrome.

Authors:  A Haraldsson; C M Weemaes; A W De Boer; J A Bakkeren; G B Stoelinga
Journal:  J Clin Immunol       Date:  1992-11       Impact factor: 8.317

Review 2.  Human memory B cells.

Authors:  M Seifert; R Küppers
Journal:  Leukemia       Date:  2016-08-08       Impact factor: 11.528

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.